The Promises and Pitfalls of Personalized Health

In this column from The Verge's Optimizer newsletter, senior reviewer Victoria Song explores the complexities of personalized health through the lens of her own experience with polycystic ovary syndrome (PCOS), recently renamed polyendocrine metabolic ovarian syndrome (PMOS). Song highlights how the global medical establishment's decision to rename the condition reflects its nature as a hormonal and metabolic disorder rather than purely a reproductive one. She illustrates the limitations of current personalized health solutions by comparing her symptoms and treatment response—such as insulin resistance and effectiveness of Metformin—with those of her esthetician, who suffers from different manifestations like cystic acne and responds better to dietary changes. The article argues that while personalized health is considered the holy grail of medicine, algorithms currently struggle to account for the vast variability in how chronic conditions manifest in different individuals. Song uses this personal narrative to critique the overpromising nature of health tech companies and wellness influencers who claim their gadgets can universally optimize health, emphasizing that effective treatment often requires nuanced, individualized approaches that technology has yet to fully master.